Stocks/SLXN

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

SLXN

↓ PDF (Pro)
Silexion Therapeutics Corp Ordinary Shares
HealthcareBiotechnologyIsraelNASDAQ
$0.62
-2.05%today
MKT CAP
$2M
-41.0% · 1Y
Earnings History
+15.3%
-
Q3 '25
Q4 '25
Analyst Targets
Current price
$0.62
Low
$6.00
Analyst Mean
$6.00
High
$6.00
2 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA0.2x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-
Debt / Equity78.22x
Free Cash Flow$-6,507,125
Insider Ownership8.3%
Institutional Ownership4.2%
Short % of Float1.36%
Days to Cover0.6d
1 Week+8.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
SHIRVAN MITCHELL PHDOfficerSale22,818$1.36$0.03M2026-03-26
SHIRVAN MITCHELL PHDOfficerStock49,726$0.00$0.00M2026-02-20
HADAR ILANChief Executive OfficerStock64,350$0.00$0.00M2026-02-20
ALON RUTHDirectorStock9,091$0.00$0.00M2026-02-20
HORENSHTEIN HADAR MIRITChief Financial OfficerStock49,726$0.00$0.00M2026-02-20
Top Holders
HolderType% HeldValueΔ SharesAs of
Citadel Advisors Llcinstitution0.30%$0.00B+100.00%2025-12-31
Montag A & Associates Incinstitution0.07%$0.00B+0.00%2026-03-31
Fidelity NASDAQ Composite Index Fundfund0.03%$0.00B+0.00%2024-10-31
Pflug Koory, LLCinstitution0.01%$0.00B+0.00%2026-03-31
UBS Group AGinstitution0.01%$0.00B-69.43%2026-03-31
Jones Financial Companies, L.L.L.P.institution0.00%$0.00B+100.00%2025-12-31
SBI Securities Co., Ltd.institution0.00%$0.00B-98.11%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for SLXN.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.